Despite its leadership in pharmaceutical products for diabetes, Sanofi is not a market leader in blood glucose meters and devices, with firms such as Abbott Diabetes Care and Bayer having a ...
While Sanofi is winding up its R&D operations in diabetes it is turning to digital solutions to get the most from its established products for ... Diabetes Shared Care Network over the next ...
MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
Sanofi engages in the research ... of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development ...
Sanofi, Breakthrough T1D UK, and Beano have partnered to create a bespoke comic strip to raise awareness of autoimmune Type 1 ...
In a report released today, Richard Vosser from J.P. Morgan maintained a Hold rating on Sanofi (SNYNF – Research Report), with a price ...